Week In Review: CStone’s Hong Kong IPO To Raise $304 Million At $1.5 Billion Valuation Next Week

, , Comments Off on Week In Review: CStone’s Hong Kong IPO To Raise $304 Million At $1.5 Billion Valuation Next Week

China will reduce the Value Added Tax on 21 rare disease treatments to 3%, starting March 1. CStone Pharma, a Suzhou oncology company, plans to raise $304 million in its Hong Kong IPO at a …
( read original story …)